חובות לטווח קצר של החברה: aptorumgroup.com (APM)

Aptorum Group Limited relies on patents in the field of orphan diseases and AI diagnostics. GURU.Markets clearly illustrates the amount of short-term financial debt, with the metric currently standing at 0.00. However, the lack of internal cash flow and dependence on external financing create risks, which are further exacerbated by the complexity of global coordination for raw material supplies used in biopharmaceutical research.

Short-term debts reflect the aggregate of obligations with a maturity of up to one year, measuring the company's ability to service current payments without raising emergency capital. For Aptorum Group Limited (APM), with its capital-intensive development portfolio in oncology and infectious diseases, the value of short-term debt serves as a liquidity indicator, allowing for an assessment of the risk of a cash gap when financing parallel clinical trials.